Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.

Laura E FischerSebastian StintzingLudwig Fischer von WeikersthalDominik P ModestThomas DeckerAlexander KianiFlorian KaiserSalah-Eddin Al-BatranTobias HeintgesChristian LerchenmüllerChristoph KahlGernot SeipeltFrank KullmannMartina StauchWerner ScheithauerClemens Giessen-JungJens UhligBettina PeuserClaudio DenzlingerArndt StahlerLena WeissKathrin HeinrichSwantje HeldAndreas JungThomas KirchnerVolker Heinemann

Published in: British journal of cancer (2022)

FIRE-3 (NCT00433927).

Keyphrases

metastatic colorectal cancer
wild type
physical activity
open label
study protocol
squamous cell carcinoma
radiation therapy
combination therapy
locally advanced